Announcements Trials
Browse Landscape

Phase

Phase NA 32Phase 4 3Phase 3 3Phase 2/3 3Phase 2 3Phase 1/2 2

Status

Recruiting 5Withdrawn 2Unknown 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ulcer 1Stomatitis 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Standard of Care × Clear all
NCT06109961 2023-11-07

HYPNOTIC

Ottawa Hospital Research Institute

Phase 1/2 Unknown
40 enrolled

Inflammatory Bowel Diseases

NCT05664906 2022-12-27

Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients

Chinese University of Hong Kong

Phase 1/2 Unknown
40 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡